mouse anti-pgc-1a antibody Search Results


rabbit anti pgc1a  (Novus Biologicals)
96
Novus Biologicals rabbit anti pgc1a
Rabbit Anti Pgc1a, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-pgc-1a+antibody/PGC1+alpha+Antibody+-+BSA+Free/pm31513844-99-3-7
Average 96 stars, based on 1 article reviews
rabbit anti pgc1a - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
rabbit anti pgc 1a antibody  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology rabbit anti pgc 1a antibody
Figure 4. Elevating <t>PGC-1a</t> Expression in Skeletal Muscle of SOD1G37R Mutant Mice Does Not Alter ALS Disease Course or Pathogenesis (A) Plot of ages (in days) at which disease onset (as determined by the weight peak; at onset, animals do not display any obvious motor phenotype), symptomatic stage (as determined by 10% weight loss from onset, a stage characterized by clear gait abnormalities and tremor) and end-stage (as determined by hindlimb paralysis and inability to right itself) were reached for SOD1G37R (red) and SOD1G37R/MCK-PGC-1a (blue) animals. (B–D) Quantification of innervation at the neuromuscular junction of the gastrocnemius muscle (B), total number of a-motor axons in the lumbar L5 motor root (C), and quantification at disease end-stage of the average number of large cholinergic ventral horn motor neurons per section of lumbar spinal cord from SOD1G37R and SOD1G37R/MCK-PGC-1a animals (D). Data are presented as mean ± SEM. See also Figure S4 for representative sections of the spinal cords used for quantification. (E) Representative micrographs of lumbar spinal cord sections from SOD1G37R and SOD1G37R/MCK-PGC-1a animals at disease end-stage processed for immuno- fluorescence using antibodies detecting activated astrocytes (GFAP) or microglia (IbaI). Dashed outlines correspond to the boundary between gray and white matter.
Rabbit Anti Pgc 1a Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-pgc-1a+antibody/Rab+1A+Antibody/pm22560226-92-6-9
Average 93 stars, based on 1 article reviews
rabbit anti pgc 1a antibody - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
pgc 1a antibody  (Santa Cruz Biotechnology)
96
Santa Cruz Biotechnology pgc 1a antibody
Figure 4. Elevating <t>PGC-1a</t> Expression in Skeletal Muscle of SOD1G37R Mutant Mice Does Not Alter ALS Disease Course or Pathogenesis (A) Plot of ages (in days) at which disease onset (as determined by the weight peak; at onset, animals do not display any obvious motor phenotype), symptomatic stage (as determined by 10% weight loss from onset, a stage characterized by clear gait abnormalities and tremor) and end-stage (as determined by hindlimb paralysis and inability to right itself) were reached for SOD1G37R (red) and SOD1G37R/MCK-PGC-1a (blue) animals. (B–D) Quantification of innervation at the neuromuscular junction of the gastrocnemius muscle (B), total number of a-motor axons in the lumbar L5 motor root (C), and quantification at disease end-stage of the average number of large cholinergic ventral horn motor neurons per section of lumbar spinal cord from SOD1G37R and SOD1G37R/MCK-PGC-1a animals (D). Data are presented as mean ± SEM. See also Figure S4 for representative sections of the spinal cords used for quantification. (E) Representative micrographs of lumbar spinal cord sections from SOD1G37R and SOD1G37R/MCK-PGC-1a animals at disease end-stage processed for immuno- fluorescence using antibodies detecting activated astrocytes (GFAP) or microglia (IbaI). Dashed outlines correspond to the boundary between gray and white matter.
Pgc 1a Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-pgc-1a+antibody/PGC-1%CE%B1+Antibody/bio_rxiv__2025__01__08__632056-245-87-92
Average 96 stars, based on 1 article reviews
pgc 1a antibody - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
anti pgc1a  (Proteintech)
96
Proteintech anti pgc1a
Figure 4. Elevating <t>PGC-1a</t> Expression in Skeletal Muscle of SOD1G37R Mutant Mice Does Not Alter ALS Disease Course or Pathogenesis (A) Plot of ages (in days) at which disease onset (as determined by the weight peak; at onset, animals do not display any obvious motor phenotype), symptomatic stage (as determined by 10% weight loss from onset, a stage characterized by clear gait abnormalities and tremor) and end-stage (as determined by hindlimb paralysis and inability to right itself) were reached for SOD1G37R (red) and SOD1G37R/MCK-PGC-1a (blue) animals. (B–D) Quantification of innervation at the neuromuscular junction of the gastrocnemius muscle (B), total number of a-motor axons in the lumbar L5 motor root (C), and quantification at disease end-stage of the average number of large cholinergic ventral horn motor neurons per section of lumbar spinal cord from SOD1G37R and SOD1G37R/MCK-PGC-1a animals (D). Data are presented as mean ± SEM. See also Figure S4 for representative sections of the spinal cords used for quantification. (E) Representative micrographs of lumbar spinal cord sections from SOD1G37R and SOD1G37R/MCK-PGC-1a animals at disease end-stage processed for immuno- fluorescence using antibodies detecting activated astrocytes (GFAP) or microglia (IbaI). Dashed outlines correspond to the boundary between gray and white matter.
Anti Pgc1a, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-pgc-1a+antibody/PGC1a+Antibody/pmc09178376-23-51-52
Average 96 stars, based on 1 article reviews
anti pgc1a - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
resource source identifier rabbit anti-pgc-1a santa cruz sc-13067 rabbit anti-gsk3b cell signaling tech  (Cell Signaling Technology Inc)
92
Cell Signaling Technology Inc resource source identifier rabbit anti-pgc-1a santa cruz sc-13067 rabbit anti-gsk3b cell signaling tech
Figure 4. Elevating <t>PGC-1a</t> Expression in Skeletal Muscle of SOD1G37R Mutant Mice Does Not Alter ALS Disease Course or Pathogenesis (A) Plot of ages (in days) at which disease onset (as determined by the weight peak; at onset, animals do not display any obvious motor phenotype), symptomatic stage (as determined by 10% weight loss from onset, a stage characterized by clear gait abnormalities and tremor) and end-stage (as determined by hindlimb paralysis and inability to right itself) were reached for SOD1G37R (red) and SOD1G37R/MCK-PGC-1a (blue) animals. (B–D) Quantification of innervation at the neuromuscular junction of the gastrocnemius muscle (B), total number of a-motor axons in the lumbar L5 motor root (C), and quantification at disease end-stage of the average number of large cholinergic ventral horn motor neurons per section of lumbar spinal cord from SOD1G37R and SOD1G37R/MCK-PGC-1a animals (D). Data are presented as mean ± SEM. See also Figure S4 for representative sections of the spinal cords used for quantification. (E) Representative micrographs of lumbar spinal cord sections from SOD1G37R and SOD1G37R/MCK-PGC-1a animals at disease end-stage processed for immuno- fluorescence using antibodies detecting activated astrocytes (GFAP) or microglia (IbaI). Dashed outlines correspond to the boundary between gray and white matter.
Resource Source Identifier Rabbit Anti Pgc 1a Santa Cruz Sc 13067 Rabbit Anti Gsk3b Cell Signaling Tech, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-pgc-1a+antibody/SignalSilence+SET8+siRNA+I/pm29768193-139-2-13
Average 92 stars, based on 1 article reviews
resource source identifier rabbit anti-pgc-1a santa cruz sc-13067 rabbit anti-gsk3b cell signaling tech - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier
anti-phospho-ampk (thr172) primary antibodies  (Beijing ComWin Biotech Co)
90
Beijing ComWin Biotech Co anti-phospho-ampk (thr172) primary antibodies
Figure 4. Elevating <t>PGC-1a</t> Expression in Skeletal Muscle of SOD1G37R Mutant Mice Does Not Alter ALS Disease Course or Pathogenesis (A) Plot of ages (in days) at which disease onset (as determined by the weight peak; at onset, animals do not display any obvious motor phenotype), symptomatic stage (as determined by 10% weight loss from onset, a stage characterized by clear gait abnormalities and tremor) and end-stage (as determined by hindlimb paralysis and inability to right itself) were reached for SOD1G37R (red) and SOD1G37R/MCK-PGC-1a (blue) animals. (B–D) Quantification of innervation at the neuromuscular junction of the gastrocnemius muscle (B), total number of a-motor axons in the lumbar L5 motor root (C), and quantification at disease end-stage of the average number of large cholinergic ventral horn motor neurons per section of lumbar spinal cord from SOD1G37R and SOD1G37R/MCK-PGC-1a animals (D). Data are presented as mean ± SEM. See also Figure S4 for representative sections of the spinal cords used for quantification. (E) Representative micrographs of lumbar spinal cord sections from SOD1G37R and SOD1G37R/MCK-PGC-1a animals at disease end-stage processed for immuno- fluorescence using antibodies detecting activated astrocytes (GFAP) or microglia (IbaI). Dashed outlines correspond to the boundary between gray and white matter.
Anti Phospho Ampk (Thr172) Primary Antibodies, supplied by Beijing ComWin Biotech Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-pgc-1a+antibody/anti+phospho+ampk++thr172++primary+antibodies/10__1016_slash_j__arabjc__2022__104313-42-4-20
Average 90 stars, based on 1 article reviews
anti-phospho-ampk (thr172) primary antibodies - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
anti pgc 1a  (Cell Signaling Technology Inc)
96
Cell Signaling Technology Inc anti pgc 1a
Figure 4. Elevating <t>PGC-1a</t> Expression in Skeletal Muscle of SOD1G37R Mutant Mice Does Not Alter ALS Disease Course or Pathogenesis (A) Plot of ages (in days) at which disease onset (as determined by the weight peak; at onset, animals do not display any obvious motor phenotype), symptomatic stage (as determined by 10% weight loss from onset, a stage characterized by clear gait abnormalities and tremor) and end-stage (as determined by hindlimb paralysis and inability to right itself) were reached for SOD1G37R (red) and SOD1G37R/MCK-PGC-1a (blue) animals. (B–D) Quantification of innervation at the neuromuscular junction of the gastrocnemius muscle (B), total number of a-motor axons in the lumbar L5 motor root (C), and quantification at disease end-stage of the average number of large cholinergic ventral horn motor neurons per section of lumbar spinal cord from SOD1G37R and SOD1G37R/MCK-PGC-1a animals (D). Data are presented as mean ± SEM. See also Figure S4 for representative sections of the spinal cords used for quantification. (E) Representative micrographs of lumbar spinal cord sections from SOD1G37R and SOD1G37R/MCK-PGC-1a animals at disease end-stage processed for immuno- fluorescence using antibodies detecting activated astrocytes (GFAP) or microglia (IbaI). Dashed outlines correspond to the boundary between gray and white matter.
Anti Pgc 1a, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-pgc-1a+antibody/PGC-1alpha+Rabbit+mAb/pm38390505-43-24-25
Average 96 stars, based on 1 article reviews
anti pgc 1a - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
anti-ampk  (Beijing ComWin Biotech Co)
90
Beijing ComWin Biotech Co anti-ampk
Figure 4. Elevating <t>PGC-1a</t> Expression in Skeletal Muscle of SOD1G37R Mutant Mice Does Not Alter ALS Disease Course or Pathogenesis (A) Plot of ages (in days) at which disease onset (as determined by the weight peak; at onset, animals do not display any obvious motor phenotype), symptomatic stage (as determined by 10% weight loss from onset, a stage characterized by clear gait abnormalities and tremor) and end-stage (as determined by hindlimb paralysis and inability to right itself) were reached for SOD1G37R (red) and SOD1G37R/MCK-PGC-1a (blue) animals. (B–D) Quantification of innervation at the neuromuscular junction of the gastrocnemius muscle (B), total number of a-motor axons in the lumbar L5 motor root (C), and quantification at disease end-stage of the average number of large cholinergic ventral horn motor neurons per section of lumbar spinal cord from SOD1G37R and SOD1G37R/MCK-PGC-1a animals (D). Data are presented as mean ± SEM. See also Figure S4 for representative sections of the spinal cords used for quantification. (E) Representative micrographs of lumbar spinal cord sections from SOD1G37R and SOD1G37R/MCK-PGC-1a animals at disease end-stage processed for immuno- fluorescence using antibodies detecting activated astrocytes (GFAP) or microglia (IbaI). Dashed outlines correspond to the boundary between gray and white matter.
Anti Ampk, supplied by Beijing ComWin Biotech Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-pgc-1a+antibody/anti+ampk/10__1016_slash_j__arabjc__2022__104313-42-0-20
Average 90 stars, based on 1 article reviews
anti-ampk - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
anti sert  (Proteintech)
94
Proteintech anti sert
Figure 4. Elevating <t>PGC-1a</t> Expression in Skeletal Muscle of SOD1G37R Mutant Mice Does Not Alter ALS Disease Course or Pathogenesis (A) Plot of ages (in days) at which disease onset (as determined by the weight peak; at onset, animals do not display any obvious motor phenotype), symptomatic stage (as determined by 10% weight loss from onset, a stage characterized by clear gait abnormalities and tremor) and end-stage (as determined by hindlimb paralysis and inability to right itself) were reached for SOD1G37R (red) and SOD1G37R/MCK-PGC-1a (blue) animals. (B–D) Quantification of innervation at the neuromuscular junction of the gastrocnemius muscle (B), total number of a-motor axons in the lumbar L5 motor root (C), and quantification at disease end-stage of the average number of large cholinergic ventral horn motor neurons per section of lumbar spinal cord from SOD1G37R and SOD1G37R/MCK-PGC-1a animals (D). Data are presented as mean ± SEM. See also Figure S4 for representative sections of the spinal cords used for quantification. (E) Representative micrographs of lumbar spinal cord sections from SOD1G37R and SOD1G37R/MCK-PGC-1a animals at disease end-stage processed for immuno- fluorescence using antibodies detecting activated astrocytes (GFAP) or microglia (IbaI). Dashed outlines correspond to the boundary between gray and white matter.
Anti Sert, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-pgc-1a+antibody/Serotonin+transporter+Polyclonal+antibody/pmc12184708-65-13-14
Average 94 stars, based on 1 article reviews
anti sert - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
8-ohdg polyclonal antibody  (Bioss)
96
Bioss 8-ohdg polyclonal antibody
Figure 4. Elevating <t>PGC-1a</t> Expression in Skeletal Muscle of SOD1G37R Mutant Mice Does Not Alter ALS Disease Course or Pathogenesis (A) Plot of ages (in days) at which disease onset (as determined by the weight peak; at onset, animals do not display any obvious motor phenotype), symptomatic stage (as determined by 10% weight loss from onset, a stage characterized by clear gait abnormalities and tremor) and end-stage (as determined by hindlimb paralysis and inability to right itself) were reached for SOD1G37R (red) and SOD1G37R/MCK-PGC-1a (blue) animals. (B–D) Quantification of innervation at the neuromuscular junction of the gastrocnemius muscle (B), total number of a-motor axons in the lumbar L5 motor root (C), and quantification at disease end-stage of the average number of large cholinergic ventral horn motor neurons per section of lumbar spinal cord from SOD1G37R and SOD1G37R/MCK-PGC-1a animals (D). Data are presented as mean ± SEM. See also Figure S4 for representative sections of the spinal cords used for quantification. (E) Representative micrographs of lumbar spinal cord sections from SOD1G37R and SOD1G37R/MCK-PGC-1a animals at disease end-stage processed for immuno- fluorescence using antibodies detecting activated astrocytes (GFAP) or microglia (IbaI). Dashed outlines correspond to the boundary between gray and white matter.
8 Ohdg Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-pgc-1a+antibody/8-OHdG+Polyclonal+Antibody/custom%40bs-1278r%4033615605
Average 96 stars, based on 1 article reviews
8-ohdg polyclonal antibody - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
cdc2/cdk1 polyclonal antibody  (Bioss)
94
Bioss cdc2/cdk1 polyclonal antibody
Figure 4. Elevating <t>PGC-1a</t> Expression in Skeletal Muscle of SOD1G37R Mutant Mice Does Not Alter ALS Disease Course or Pathogenesis (A) Plot of ages (in days) at which disease onset (as determined by the weight peak; at onset, animals do not display any obvious motor phenotype), symptomatic stage (as determined by 10% weight loss from onset, a stage characterized by clear gait abnormalities and tremor) and end-stage (as determined by hindlimb paralysis and inability to right itself) were reached for SOD1G37R (red) and SOD1G37R/MCK-PGC-1a (blue) animals. (B–D) Quantification of innervation at the neuromuscular junction of the gastrocnemius muscle (B), total number of a-motor axons in the lumbar L5 motor root (C), and quantification at disease end-stage of the average number of large cholinergic ventral horn motor neurons per section of lumbar spinal cord from SOD1G37R and SOD1G37R/MCK-PGC-1a animals (D). Data are presented as mean ± SEM. See also Figure S4 for representative sections of the spinal cords used for quantification. (E) Representative micrographs of lumbar spinal cord sections from SOD1G37R and SOD1G37R/MCK-PGC-1a animals at disease end-stage processed for immuno- fluorescence using antibodies detecting activated astrocytes (GFAP) or microglia (IbaI). Dashed outlines correspond to the boundary between gray and white matter.
Cdc2/Cdk1 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-pgc-1a+antibody/Cdc2%2FCDK1+Polyclonal+Antibody/custom%40bs-1341r%4033615605
Average 94 stars, based on 1 article reviews
cdc2/cdk1 polyclonal antibody - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
cd16 polyclonal antibody  (Bioss)
94
Bioss cd16 polyclonal antibody
Figure 4. Elevating <t>PGC-1a</t> Expression in Skeletal Muscle of SOD1G37R Mutant Mice Does Not Alter ALS Disease Course or Pathogenesis (A) Plot of ages (in days) at which disease onset (as determined by the weight peak; at onset, animals do not display any obvious motor phenotype), symptomatic stage (as determined by 10% weight loss from onset, a stage characterized by clear gait abnormalities and tremor) and end-stage (as determined by hindlimb paralysis and inability to right itself) were reached for SOD1G37R (red) and SOD1G37R/MCK-PGC-1a (blue) animals. (B–D) Quantification of innervation at the neuromuscular junction of the gastrocnemius muscle (B), total number of a-motor axons in the lumbar L5 motor root (C), and quantification at disease end-stage of the average number of large cholinergic ventral horn motor neurons per section of lumbar spinal cord from SOD1G37R and SOD1G37R/MCK-PGC-1a animals (D). Data are presented as mean ± SEM. See also Figure S4 for representative sections of the spinal cords used for quantification. (E) Representative micrographs of lumbar spinal cord sections from SOD1G37R and SOD1G37R/MCK-PGC-1a animals at disease end-stage processed for immuno- fluorescence using antibodies detecting activated astrocytes (GFAP) or microglia (IbaI). Dashed outlines correspond to the boundary between gray and white matter.
Cd16 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-pgc-1a+antibody/CD16+Polyclonal+Antibody/custom%40bs-6028r%4033615605
Average 94 stars, based on 1 article reviews
cd16 polyclonal antibody - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

Image Search Results


Figure 4. Elevating PGC-1a Expression in Skeletal Muscle of SOD1G37R Mutant Mice Does Not Alter ALS Disease Course or Pathogenesis (A) Plot of ages (in days) at which disease onset (as determined by the weight peak; at onset, animals do not display any obvious motor phenotype), symptomatic stage (as determined by 10% weight loss from onset, a stage characterized by clear gait abnormalities and tremor) and end-stage (as determined by hindlimb paralysis and inability to right itself) were reached for SOD1G37R (red) and SOD1G37R/MCK-PGC-1a (blue) animals. (B–D) Quantification of innervation at the neuromuscular junction of the gastrocnemius muscle (B), total number of a-motor axons in the lumbar L5 motor root (C), and quantification at disease end-stage of the average number of large cholinergic ventral horn motor neurons per section of lumbar spinal cord from SOD1G37R and SOD1G37R/MCK-PGC-1a animals (D). Data are presented as mean ± SEM. See also Figure S4 for representative sections of the spinal cords used for quantification. (E) Representative micrographs of lumbar spinal cord sections from SOD1G37R and SOD1G37R/MCK-PGC-1a animals at disease end-stage processed for immuno- fluorescence using antibodies detecting activated astrocytes (GFAP) or microglia (IbaI). Dashed outlines correspond to the boundary between gray and white matter.

Journal: Cell metabolism

Article Title: Elevated PGC-1α activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS.

doi: 10.1016/j.cmet.2012.03.019

Figure Lengend Snippet: Figure 4. Elevating PGC-1a Expression in Skeletal Muscle of SOD1G37R Mutant Mice Does Not Alter ALS Disease Course or Pathogenesis (A) Plot of ages (in days) at which disease onset (as determined by the weight peak; at onset, animals do not display any obvious motor phenotype), symptomatic stage (as determined by 10% weight loss from onset, a stage characterized by clear gait abnormalities and tremor) and end-stage (as determined by hindlimb paralysis and inability to right itself) were reached for SOD1G37R (red) and SOD1G37R/MCK-PGC-1a (blue) animals. (B–D) Quantification of innervation at the neuromuscular junction of the gastrocnemius muscle (B), total number of a-motor axons in the lumbar L5 motor root (C), and quantification at disease end-stage of the average number of large cholinergic ventral horn motor neurons per section of lumbar spinal cord from SOD1G37R and SOD1G37R/MCK-PGC-1a animals (D). Data are presented as mean ± SEM. See also Figure S4 for representative sections of the spinal cords used for quantification. (E) Representative micrographs of lumbar spinal cord sections from SOD1G37R and SOD1G37R/MCK-PGC-1a animals at disease end-stage processed for immuno- fluorescence using antibodies detecting activated astrocytes (GFAP) or microglia (IbaI). Dashed outlines correspond to the boundary between gray and white matter.

Article Snippet: Immunoblotting PGC-1a was immunoprecipitated using a rabbit anti-PGC-1a antibody (Santa Cruz; H300) from the gastrocnemius muscle of nontransgenic and MCK-PGC-1a mice.

Techniques: Expressing, Mutagenesis